Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nana Aono"'
Autor:
Seong Joon Park, Suee Lee, Yuki Akazawa, Li-Ming Peng, Xiao-dong Wang, Alessandro Lia Mondelli, Takashi Meguro, Elvira Garza-González, Ni Chen, Dae-Ho Lee, Toru Kumagai, Chun-mei Huang, Ji Hyun Lee, Atsushi Takada, Hyuk-Chan Kwon, Inkeun Park, Mineo Kudo, Minoru Uebayashi, Hiroshi Nakatsumi, Koji Oba, Satoshi Yuki, Christian A. Graves, Taishi Harada, Feng Bi, Wen Zhang, Cheryn Song, Kenichiro Nagata, Junji Uchida, Ioannis A. Voutsadakis, Zhi-ping Li, Nana Aono, Kevin Camphausen, Sung Hyun Kim, Susumu Sogabe, Antonia Digklia, Xu Li, Masanori Sueyasu, Masahiro Asaka, Shuichi Muto, Hong-Sheng Wen, Shin Ahn, Qiu-lin Tang, Yoshito Komatsu, Jae-Lyun Lee, Cui-Cui Zhang, Carlos Henrique Camargo, Druck Reinhardt Druck Basel, Sung Yong Oh, Kanji Kato, Hiroaki Ikesue, Kwonoh Park, Wei Wang, Yoichi Nakanishi, Koichi Takayama, Takako Okuyama, Adriano Martison Ferreira, Yu-Zhu Cao, Fumio Imamura, Satz Mengensatzproduktion, Fang Yang, Yongcheol Ahn, Samantha Flores, Marina Oshiro, Kazumi Nishino, Choung-Soo Kim, Ryozo Oishi, Hanjong Ahn, Hiroyuki Watanabe, Hyojin Kim, Yuri Ito, Jin-Hee Ahn, Kazuto Mishima, Qian Deng, Soraya Mendoza-Olazarán, Takuto Miyagishima, Yu-Ming Shi, Li Li, Tetsuhiro Yoshinami, Kimitaka Suetsugu, Adrián Camacho-Ortiz, Miki Tateyama, Mariana Fávero Bonesso, Jorge M. Llaca-Díaz, Maria de Lourdes Ribeiro de Souza da Cunha, Nobuaki Egashira, Jun Hyuk Hong
Publikováno v:
Chemotherapy. 58:I-VI
Autor:
Yuri Hamanaka, Daisuke Sakai, Toshinari Yagi, Naotoshi Sugimoto, Yasuhiko Tomita, Sachiko Yamamoto, Hitoshi Yoshida, Yukiko M. Yamashita, Fumio Imamura, Nana Aono, Yuki Akazawa, Jun Ishikawa, Hiroaki Masaie, Shinsuke Kusakabe, Tetsuhiro Yoshinami
Publikováno v:
International journal of hematology. 95(2)
A 56-year-old woman with Hodgkin-like adult T-cell leukemia/lymphoma was treated with allogeneic peripheral blood stem cell transplantation on 17 April 2009. She manifested a moderate fever on day 41. CT scanning and other examinations detected sligh
Autor:
Shun-ichi Isa, Akihito Kubo, Kazuyuki Tsujino, Nana Aono, Keiko Nakao, Tomoya Kawaguchi, Yasuhiro Koh, Minoru Takada, Takayasu Kurata, Kazunobu Tachibana
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 4(8)
Introduction: Gaining a higher response rate (RR) has usually been determined as a primary end point in phase II trials evaluating the efficacy of new molecular targeted drugs. However, a relationship between clinical response and survival benefit ha